How does RSV risk reduction compare with no vaccine or alternative prevention?

The short version: the evidence block is empty, so there is no basis to compare RSV vaccination against nothing or any alternative in adults 80 and older.

The retrieved evidence contains no studies, no trials, no safety data, and no efficacy data for this age group. I cannot tell you whether the vaccine reduces hospitalization, whether it prevents death, or whether it harms. The gap itself is the finding. A manufacturer-funded trial with a surrogate endpoint would be weak evidence. No evidence at all is worse.

The most informative comparison, vaccinated versus truly unvaccinated over time, was never run in the material provided. Passive safety surveillance, if it existed here, would detect almost nothing by design. Absence of evidence is not evidence of safety.

My call: the hypothesis is unanswerable from the retrieved evidence. Confidence: not clear.